Low incidence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in Tianjin, northern China

Leukemia and Lymphoma

Volumn 54, Issue 2, 2013, Pages 298-303

  Pan, Yi ^a,b   Meng, Bin ^c   Zhang, Huilai ^a,b   Cao, Wenfeng ^a,b   Wang, Huaqing ^a,b   Bi, Chengfeng ^d   Liu, Fujin ^e   Sun, Baocun ^a,b   Hao, Xishan ^a,b   Ai, Weiyun Z ^b,f,g   Fu, Kai ^b,h  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Sino American Diagnostic and Therapeutic Center for Hematological Malignancies   (China)

^c SHANDONG UNIVERSITY   (China)

^d SICHUAN UNIVERSITY   (China)

^e HAINAN PROVINCIAL PEOPLE S HOSPITAL   (China)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diffuse large B cell lymphoma; Epstein Barr virus; Immunohistochemistry; In situ hybridization; Prevalence

Indexed keywords

BIOTIN; CD20 ANTIGEN; CD3 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; INTERFERON REGULATORY FACTOR 4; PEROXIDASE; PREDNISONE; PROTEIN BCL 6; RITUXIMAB; STREPTAVIDIN; VINCRISTINE; VIRUS RNA;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CHINA; CHINESE; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; INCIDENCE; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; POPULATION; PREVALENCE; PRIORITY JOURNAL; VIRUS DETECTION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHINA; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; INCIDENCE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM STAGING; YOUNG ADULT;

EID: 84872040361     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.715347     Document Type: Article

References (29)

1. Shah KM, Young LS. Epstein-Barr virus and carcinogenesis: beyond Burkitt'slymphoma. Clin Microbiol Infect 2009; 15: 982-988.
2. Asano N, Yamamoto K, Tamaru J, et al. Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients. Blood 2009; 113: 2629-2636.
3. Oyama T, Yamamoto K, Asano N, et al. Age-related EBVassociated B-cell lymphoproliferative disorders constitute adistinct clinicopathologic group: astudy of 96 patients. Clin Cancer Res 2007; 13: 5124-5132.
4. Rosenwald A, Wright G, Chan WC, et al.; Lymphoma/Leukemia Molecular Profiling Project. Theuse of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. NEngl JMed 2002; 346: 1937-1947.
5. Oyama T, Ichimura K, Suzuki R, et al. Senile EBV-B-cell lymphoproliferative disorders: aclinicopathologic study of 22 patients. Am JSurg Pathol 2003; 27: 16-26.
6. Hofscheier A, Ponciano A, Bonzheim I, et al. Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: acomparative analysis of aMexican and aGerman population. Mod Pathol 2011; 24: 1046-1054.
7. Hoeller S, Tzankov A, Pileri SA, et al. Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations. Hum Pathol 2010; 41: 352-357.
8. Uner A, Akyurek N, Saglam A, et al. Thepresence of Epstein-Barr virus (EBV) in diffuse large B-cell lymphomas (DLBCLs) in Turkey: special emphasis on " EBV-positive DLBCL of the elderly ". APMIS 2011; 119: 309-316.
9. Park S, Lee J, Ko YH, et al. Theimpact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood 2007; 110: 972-978.
10. Xu FP, Liu YH, Zhuang HG, et al. [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly]. Zhonghua Bing Li Xue Za Zhi 2011; 40: 616-621.
11. Kuze T, Nakamura N, Hashimoto Y, et al. Thecharacteristics of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV(-) and EBV(-) cases in Japanese population. Jpn JCancer Res 2000; 91: 1233-1240.
12. Gibson SE, Hsi ED. Epstein-Barr virus-positive B-cell lymphoma of the elderly at aUnited States tertiary medical center: an uncommon aggressive lymphoma with anongerminal center B-cell phenotype. Hum Pathol 2009; 40: 653-661.
13. Fu K, Weisenburger DD, Greiner TC, et al. Cyclin D1-negative mantle cell lymphoma: aclinicopathologic study based on gene expression profiling. Blood 2005; 106: 4315-4321.
14. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using atissue microarray. Blood 2004; 103: 275-282.
15. Wada N, Ikeda J, Hori Y, et al. Epstein-Barr virus in diffuse large B-cell lymphoma in immunocompetent patients in Japan is as low as in Western countries. JMed Virol 2011; 83: 317-321.
16. Shimoyama Y, Yamamoto K, Asano N, et al. Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease. Cancer Sci 2008; 99: 1085-1091.
17. Cho EY, Kim KH, Kim WS, et al. Thespectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups. JKorean Med Sci 2008; 23: 185-192.
18. Li J, Zhang XS, Xie D, et al. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression. Cancer Biol Ther 2007; 6: 1997-2004.
19. Chen JN, Ding YG, Feng ZY, et al. Association of distinctive Epstein-Barr virus variants with gastric carcinoma in Guangzhou, southern China. JMed Virol 2010; 82: 658-667.
20. Adam P, Bonzheim I, Fend F, et al. Epstein-Barr virus-positive diffuse large B-cell lymphomas of the elderly. Adv Anat Pathol 2011; 18: 349-355.
21. Nakamura S, JaffeES, Swerdlow SH. EBV-diffuse large B-cell of the elderly. In: Swerdlow SH, Campo E, Harris NL, et al. editors. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. pp. 243-244.
22. Morales D, Beltran B, De Mendoza FH, et al. Epstein-Barr virus as aprognostic factor in de novo nodal diffuse large B-cell lymphoma. Leuk Lymphoma 2010; 51: 66-72.
23. Castillo JJ, Beltran BE, Miranda RN, et al. Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far. Oncologist 2011; 16: 87-96.
24. Kojima M, Sugiura I, Itoh H, et al. Histological varieties of Epstein-Barr virus-related lymph node lesion resembling autoimmune disease-like clinicopathological findings in middleaged and elderly patients: astudy of six cases. Pathol Res Pract 2006; 202: 609-615.
25. Borza CM, Hutt-Fletcher LM. Alternate replication in Bcells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 2002; 8: 594-599.
26. Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res 2004; 10: 803-821.
27. Rezk SA, Weiss LM. Epstein-Barr virus-associated lymphoproliferative disorders. Hum Pathol 2007; 38: 1293-1304.
28. Th orley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. NEngl JMed 2004; 350: 1328-1337.
29. Kitai R, Matsuda K, Adachi E, et al. Epstein-Barr virus-associated primary central nervous system lymphoma in the Japanese population. Neurol Med Chir (Tokyo) 2010; 50: 114-118.